About INTRABEAM
INTRABEAM – a groundbreaking irradiation system from Carl Zeiss – has already entered routine clinical practice in more than 100 medical centers worldwide as a method of targeted intraoperative radiation therapy (TARGIT) for breast cancer following breast conserving surgery. In addition to its use for TARGIT in breast cancer treatment, INTRABEAM now also offers a gentle treatment method – essentially palliative care – for spine metastases, which can also occur as a result of breast cancer. The spine metastases are irradiated directly within the spine in a minimally invasive procedure which involves inserting the INTRABEAM radiation source into the spine through a narrow gap of just a few millimeters using a special applicator and delivering a precise dose of radiation to the target tissue. The spine is subsequently stabilized using a procedure known as kyphoplasty.

A minimal invasive access is created to the collapsed vertebral body containing the painful bone metastasis. The tumour is then radiated at its precise location with INTRABEAM. The radiation time is less than 2 minutes.